Abbott and Zurich University link up on CJD (Creutzfeldt-Jakob disease) test:
This article was originally published in Clinica
Executive Summary
Abbott Laboratories and the University of Zurich have set up a research collaboration to develop in vitro diagnostic tests for neurodegenerative diseases that are related to the presence of abnormal prion proteins, such as those associated with Creutzfeldt-Jakob Disease (CJD). Under the licensing agreement, Abbott obtains non-exclusive rights to the university's existing technologies for binding prions associated with the disease, plus exclusive rights to any improvements that arise from the collaboration.